Latest Expert Witness News

Parexel Appoints Leading Central Nervous System Experts to Its Clinical Pharmacology Business

Parexel International Corporation, a leading global biopharmaceutical services organization, announced that Larry Ereshefsky, Pharm.D., F.C.C.P., B.C.C.P., and Malek Bajbouj, M.D., have  been appointed as Vice Presidents of Clinical Pharmacology Consulting Services in the Company's international clinical pharmacology business.

These leading experts advise clients on early phase clinical development in the central nervous system (CNS) therapeutic area, including in regard to psychiatry, neuropsychopharmacology, and neurophysiology clinical studies. Dr. Ereshefsky is based at Parexels’  Clinical Pharmacology Research Unit in Los Angeles, and Dr. Bajbouj is based at the unit in Berlin, Germany.

"Clients increasingly rely on our experts to help identify and select the most promising compounds in the Phase I and Proof of Concept stages. These decisions are based on demonstrating safety and signals of efficacy as early as possible in the drug development process," said Herman Scholtz, M.D., Corporate Vice President and Worldwide Head, Clinical Pharmacology.

"We expect that the extensive medical and scientific expertise Dr. Ereshefsky and Dr. Bajbouj bring to our clinical pharmacology business will further strengthen our central nervous system capabilities in order to help biopharmaceutical companies address growing complexity in this important area of early phase clinical development."

back